Milestone Pharmaceuticals Inc.
MIST· Nasdaq
MISTMilestone Pharmaceuticals Inc.
Filed Mar 13, 2025 · 10-K · 72 days after period end · 0001558370-25-002849
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$12.36M | -$13.61M | -$13.18M | -$16.88M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 13, 2025 · 72 d after period end
